Adjuvant therapy for breast cancer
https://libcat.nshealth.ca/en/permalink/provcat30193
- Available Online
- View e-Book
- Other Authors
- Castiglione, Monica
- Piccart, Martine J
- Place of Publication
- Boston, MA
- Publisher
- Springer-Verlag US
- Date of Publication
- c2009
- Series Vol.
- 151
- Series Title
- Cancer treatment and research
- ISBN
- 9780387751153
- Subjects (MeSH)
- Adjuvants, Pharmaceutic
- Breast Neoplasms - therapy
- Chemotherapy, Adjuvant
- Radiotherapy, Adjuvant
- Subjects (LCSH)
- Oncology
- Gynecology
- Format
- e-Book
- Location
- Online
Antibiotic and chemotherapy : anti-infective agents and their use in therapy
https://libcat.nshealth.ca/en/permalink/provcat31781
[edited by] Roger Finch ... [et al.].
(9th ed.)
--Edinburgh, Scotland:
Saunders Elsevier
, 2010.
- Available Online
- View e-Book
- Access
- Registration required for PDF access.
- Location
- Online
- Available Online
- View e-Book
- Other Authors
- Finch, R. G
- Responsibility
- [edited by] Roger Finch ... [et al.]
- Edition
- 9th ed.
- Place of Publication
- Edinburgh, Scotland
- Publisher
- Saunders Elsevier
- Date of Publication
- 2010
- Physical Description
- 1 online resource (xii, 900 p.)
- ISBN
- 9780702047657
- Subjects (MeSH)
- Anti-Bacterial Agents - therapeutic use
- Infection - drug therapy
- Subjects (LCSH)
- Anti-infective agents
- Antibiotics
- Chemotherapy
- Anti-Bacterial Agents - therapeutic use
- Infection - drug therapy
- Contents
- pt. 1. General aspects -- pt. 2. Agents -- pt. 3. Treatment.
- Access
- Registration required for PDF access.
- Format
- e-Book
- Location
- Online
Brody's human pharmacology : mechanism-based therapeutics
https://libcat.nshealth.ca/en/permalink/provcat31483
[edited by] Lynn Wecker ; with David A. Taylor.
(6th ed.)
--Philadelphia, PA:
Elsevier
, c2019.
- Available Online
- View e-Book
- Access
- Registration required for PDF access.
- Location
- Online
Focusing on the essential aspects of pharmacology you need to know, Brody‘s Human Pharmacology, 6th Edition, keeps you fully up to date with all that’s new in the field. Streamlined content, a new organizational approach, enhanced online components, and thoroughly updated information ensure your grasp of key concepts and prepare you for exams. Nearly 500 full-color illustrations explain important processes, while color-coded boxes for major drugs, therapeutic overviews, clinical problems, and …
- Available Online
- View e-Book
- Other Authors
- Wecker, Lynn
- Responsibility
- [edited by] Lynn Wecker ; with David A. Taylor
- Edition
- 6th ed.
- Alternate Title
- Human pharmacology
- Place of Publication
- Philadelphia, PA
- Publisher
- Elsevier
- Date of Publication
- c2019
- Physical Description
- 1 online resource, 728 p.
- ISBN
- 9780323476522
- Subjects (MeSH)
- Pharmacology
- Pharmacological Phenomena
- Subjects (LCSH)
- Pharmacology
- Chemotherapy
- Drug Therapy
- Specialty
- Pharmacology
- Abstract
- Focusing on the essential aspects of pharmacology you need to know, Brody‘s Human Pharmacology, 6th Edition, keeps you fully up to date with all that’s new in the field. Streamlined content, a new organizational approach, enhanced online components, and thoroughly updated information ensure your grasp of key concepts and prepare you for exams. Nearly 500 full-color illustrations explain important processes, while color-coded boxes for major drugs, therapeutic overviews, clinical problems, and trade names reinforce your mastery of the information.
- Access
- Registration required for PDF access.
- Format
- e-Book
- Location
- Online
Cancer Regional Therapy : HAI, HIPEC, HILP, ILI, PIPAC and Beyond
https://libcat.nshealth.ca/en/permalink/provcat45119
Yuman Fong, T. Clark Gamblin, Ernest S. Han, Byrne Lee, Jonathan S. Zager, editors.
--Cham:
Springer
, c2020.
- Available Online
- View e-Book
- Location
- Online
This book is a state-of-the-art overview of cancer regional therapy (CRT) for the surgeons and interventional radiologists active in CRT development and research. The goals of this book are 1) to review the theory and practice of cancer regional therapies including pharmacology, devices, techniques, and workflow, 2) illustrate the most common procedures performed in the interventional and operating rooms, and 3) discuss data supporting use of CRT. This is meant to be a definitive text on the th…
- Available Online
- View e-Book
- Other Authors
- Fong, Yuman
- Gamblin, T. Clark
- Han, Ernest S.
- Lee, Byrne
- Zager, Jonathan S.
- Responsibility
- Yuman Fong, T. Clark Gamblin, Ernest S. Han, Byrne Lee, Jonathan S. Zager, editors
- Place of Publication
- Cham
- Publisher
- Springer
- Date of Publication
- c2020
- Physical Description
- 1 online resource (xxvi, 488 p.) : 86 illus., 64 illus. in color
- ISBN
- 9783030288914
- 9783030288907 (Print ed.)
- 9783030288921 (Print ed.)
- 9783030288938 (Print ed.)
- Subjects (MeSH)
- Chemotherapy, Cancer, Regional Perfusion
- Neoplasm Invasiveness - prevention & control
- Neoplasm Metastasis
- Neoplasms - therapy
- Specialty
- Medical Oncology
- Abstract
- This book is a state-of-the-art overview of cancer regional therapy (CRT) for the surgeons and interventional radiologists active in CRT development and research. The goals of this book are 1) to review the theory and practice of cancer regional therapies including pharmacology, devices, techniques, and workflow, 2) illustrate the most common procedures performed in the interventional and operating rooms, and 3) discuss data supporting use of CRT. This is meant to be a definitive text on the theory and practice of CRT. It begins with a summary of the history, technical principles that underlie regional therapy. The following parts discuss current data and practice in peritoneal, liver, limb, pleural and other sites. Included in the practice are considerations of workflow and financial issues revolving around CRT. Novel techniques and therapies under investigation are presented to inform the direction of the field. Cancer Regional Therapy summarizes the history, current technology, common procedures, and future prospects in this field and includes procedures from many surgical and interventional radiologic disciplines.
- Contents
- Part I. Background -- 1. The Basis of Regional Therapy, Pharmacology, Hyperthermia, and Drug Resistance -- 2. Novel Biological Therapies with Direct Application to the Peritoneal Cavity -- 3. Y-90 Radiomicrosphere Therapy: Principles and Clinical Use in Colorectal Cancer Liver Metastases -- 4. Principles of Percutaneous Ablation in the Liver -- 5. Regional Gene Therapy for Cancer -- Part II. Peritoneal Regional Therapy for Cancer -- 6. Historical Perspective for Regional Peritoneal Therapy: HIPEC, EPIC, and Port-Based Therapy -- 7. Rationale Behind HIPEC/Molecular and Genetic Considerations in HIPEC -- 8 .Data for HIPEC for Pseudomyxoma Peritonei/Tumors of the Appendix -- 9. Data for HIPEC in Colorectal Cancer (T4 Lesions and Metastases) -- 10. Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Peritoneal Metastasis of Gastric Cancer -- 11. Regional Therapy for the Treatment of Ovarian Cancer: HIPEC and Intraperitoneal Chemotherapy -- 12. Mesothelioma and Miscellaneous Disease Processes -- Part III. Perioperative Considerations for HIPEC -- 13. Anesthetic Considerations for Regional Therapies -- 14. Postoperative Management of Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy -- 15. Complications of Cytoreductive Surgery and HIPEC -- 16. Liver Resection and HIPEC -- 17. Peritoneal Perfusion Techniques -- 18. Operative Pearls for Cytoreduction of the Difficult Abdomen and Pelvis -- 19. Novel Techniques and the Future of HIPEC (Immunotherapy, Viral Therapy) -- 20. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) -- Part IV. Liver Infusional and Perfusional Therapies -- 21. The History of Isolated Hepatic Perfusion for Liver Metastases and Current Indications for Use -- 22. Pump-Based Hepatic Arterial Infusional Therapy -- 23. Percutaneous Transcatheter Particle Therapies -- 24. Hepatic Perfusion: Surgical and Catheter -- 25. Percutaneous and Port Delivered Arterial Infusional Therapy for Liver Tumors -- 26. Regional Therapies in Hepatocellular Carcinoma and Cholangiocarcinoma -- 27. Regional Therapies for Hepatic Melanoma Metastases -- 28. Complications of Intra-Arterial Regional Liver Therapy -- Part V. Limb Infusional and Perfusional Therapies -- 29. Infusion Technique -- 30. Hyperthermic Isolated Limb Perfusion for Melanoma -- 31. Isolated Limb Perfusion and Infusion in the Management of In-Transit Melanoma of the Extremities: Modern Data Affecting Practice -- 32. Trial Data for Sarcoma -- Part VI. Other Regional Therapies -- 33. Regional Therapy of Bladder Tumors -- 34. Delivery of Antineoplastic Therapeutics to the Central Nervous System -- 35. Intralesional Therapies: Oncolytic Viral Therapies, Immunostimulants -- 36. Ongoing Clinical Trials and Rationale in Regional and Oligometastatic Disease -- 37. Radiation Therapy.
- Format
- e-Book
- Location
- Online
Cancer related brain fog
https://libcat.nshealth.ca/en/permalink/chpams37382
Nova Scotia Health Authority. Central Zone. Radiation Team, Nova Scotia Health. Cancer Care Program.
Halifax, NS:
Nova Scotia Health Cancer Care Program
, 2022.
- Pamphlet Number
- 4029
- Available Online
- View Pamphlet
Cancer patients and survivors can be frustrated by the mental cloudiness they notice before, during, and after cancer treatment. This common cancer side effect is called Brain Fog or Chemo Brain. The term Chemo Brain can be misleading as chemotherapy is not the only cause of concentration and memory problems. This pamphlet explains what brain fog is, what causes it, the risk factors for brain fog, and what you can do to manage it. A list of resources for further information is included.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Central Zone. Radiation Team
- Nova Scotia Health. Cancer Care Program
- Alternate Title
- Cancer-related brain fog
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Cancer Care Program
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Drug-Related Side Effects and Adverse Reactions
- Neoplasms - complications
- Neoplasms - psychology
- Patients - psychology
- Subjects (LCSH)
- Cancer--Chemotherapy--Complications
- Cancer--Patients--Psychology
- Specialty
- Cancer Care
- Abstract
- Cancer patients and survivors can be frustrated by the mental cloudiness they notice before, during, and after cancer treatment. This common cancer side effect is called Brain Fog or Chemo Brain. The term Chemo Brain can be misleading as chemotherapy is not the only cause of concentration and memory problems. This pamphlet explains what brain fog is, what causes it, the risk factors for brain fog, and what you can do to manage it. A list of resources for further information is included.
- Responsibility
- Prepared by: NSH Central Zone Radiation Team
- Pamphlet Number
- 4029
IWK. Pharmacy.
Halifax, NS:
IWK Health Centre
, 2019.
- Pamphlet Number
- PL-1204
- Available Online
- View Pamphlet
Captopril - This medicine is used to treat high blood pressure and heart failure. Captopril is a medicine that lowers blood pressure and reduces the amount of work the heart has to do.
- Available Online
- View Pamphlet
- Corporate Author
- IWK. Pharmacy
- Alternate Title
- Dissolve-A-Dose® System
- Place of Publication
- Halifax, NS
- Publisher
- IWK Health Centre
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document : digital, PDF file
- Subjects (MeSH)
- Antihypertensive Agents
- Captopril
- Hypertension - drug therapy
- Subjects (LCSH)
- Captopril
- Hypertension--Chemotherapy
- Hypotensive agents
- Abstract
- Captopril - This medicine is used to treat high blood pressure and heart failure. Captopril is a medicine that lowers blood pressure and reduces the amount of work the heart has to do.
- Responsibility
- IWK NICU Pharmacy Team, Halifax, NS
- Pamphlet Number
- PL-1204
IWK. Pharmacy.
Halifax, NS:
IWK Health Centre
, 2019.
- Pamphlet Number
- PL-1205
- Available Online
- View Pamphlet
Cephalexin is an antibiotic used to treat infection caused by bacteria. It is sometimes used in lower doses to prevent infection.
- Available Online
- View Pamphlet
- Corporate Author
- IWK. Pharmacy
- Place of Publication
- Halifax, NS
- Publisher
- IWK Health Centre
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document : digital, PDF file
- Subjects (MeSH)
- Anti-Infective Agents
- Cephalexin
- Pharmaceutical Preparations
- Subjects (LCSH)
- Antibiotics
- Infection--Treatment
- Infection in children--Chemotherapy
- Abstract
- Cephalexin is an antibiotic used to treat infection caused by bacteria. It is sometimes used in lower doses to prevent infection.
- Responsibility
- IWK NICU Pharmacy Team, Halifax, NS
- Pamphlet Number
- PL-1205
Cytotoxic precautions at home
https://libcat.nshealth.ca/en/permalink/chpams37335
Nova Scotia Health. Nova Scotia Cell Therapy and Transplant Program.
Halifax, NS:
Nova Scotia Health Cancer Care Program
, 2022.
- Pamphlet Number
- 4037
- Available Online
- View Pamphlet
You are being treated with a cancer treatment that is cytotoxic. This means it can kill cancer cells and can harm healthy cells. This booklet describes what you, your family, friends and caregivers need to know about cytotoxic precautions. These precautions are used to keep your family members, friends and caregivers safe while you are taking your cancer treatment. This pamphlet explains what cytotoxic precautions are, what body fluids are cytotoxic, how to handle your body wastes, what to do …
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health. Nova Scotia Cell Therapy and Transplant Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Cancer Care Program
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (5 p.) : digital, PDF file
- Subjects (MeSH)
- Neoplasms - drug therapy
- Patient Safety
- Cytotoxins--toxicity
- Subjects (LCSH)
- Cancer--Chemotherapy
- Patient safety
- Specialty
- Cancer Care
- Medications
- Abstract
- You are being treated with a cancer treatment that is cytotoxic. This means it can kill cancer cells and can harm healthy cells. This booklet describes what you, your family, friends and caregivers need to know about cytotoxic precautions. These precautions are used to keep your family members, friends and caregivers safe while you are taking your cancer treatment. This pamphlet explains what cytotoxic precautions are, what body fluids are cytotoxic, how to handle your body wastes, what to do if your body wastes spill and what to do with the garbage. Information about dishes, laundry, sex, having a baby, breastfeeding, and how to bring samples to the hospital is included.
- Responsibility
- Prepared by: Nova Scotia Cell Therapy and Transplant Program
- Pamphlet Number
- 4037
Drug interaction facts 2015 : the authority on drug interactions
https://libcat.nshealth.ca/en/permalink/provcat38419
editor, David S. Tatro.
--St. Louis, MO:
Wolters Kluwer Health
, 2015.
- Call Number
- QV 39 D794 2015
- Location
- Cape Breton Regional
- Call Number
- QV 39 D794 2015
- Other Authors
- Tatro, David S.
- Responsibility
- editor, David S. Tatro
- Place of Publication
- St. Louis, MO
- Publisher
- Wolters Kluwer Health
- Date of Publication
- 2015
- Physical Description
- lviii, 2486 p.
- ISBN
- 9781574393637 (pbk.)
- 1574393634 (pbk.)
- Subjects (MeSH)
- Drug Interactions
- Drug Therapy, Combination
- Subjects (LCSH)
- Drug interactions--Handbooks, manuals, etc.
- Chemotherapy, Combination--Handbooks, manuals, etc.
- Format
- Book
- Location
- Cape Breton Regional
Erythropoieis-stimulating agents (ESAs) for chronic kidney disease (CKD) : with active cancer or a history of cancer or stroke
https://libcat.nshealth.ca/en/permalink/chpams37446
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2021.
- Pamphlet Number
- 2217
- Available Online
- View Pamphlet
Erythropoiesis-stimulating agents (ESAs) are a group of medicines that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This can cause their red blood cell count to drop and anemia (not enough red blood cells or hemoglobin in the blood) to develop. If you have CKD and active cancer or a history of cancer of stroke, it is important to carefully …
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2021
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (MeSH)
- Renal insufficiency, chronic - complications
- Anemia - drug therapy
- Hematinics - therapeutic use
- Neoplasms
- Stroke
- Subjects (LCSH)
- Chronic renal failure--Complications
- Hematopoietic growth factors
- Renal anemia--Chemotherapy
- Cancer
- Cerebrovascular disease
- Abstract
- Erythropoiesis-stimulating agents (ESAs) are a group of medicines that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This can cause their red blood cell count to drop and anemia (not enough red blood cells or hemoglobin in the blood) to develop. If you have CKD and active cancer or a history of cancer of stroke, it is important to carefully consider the risks and benefits of ESAs. The risks and benefits of ESAs are listed. Your health care team will talk with you about the risks and benefits of ESAs and other factors to consider when making the decision to take ESAs.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 2217
Erythropoiesis-stimulating agent (ESA) therapy and chronic kidney disease (CKD)
https://libcat.nshealth.ca/en/permalink/chpams35406
Nova Scotia Health Authority. Renal Program.
Halifax, NS:
Nova Scotia Health Authority
, 2020.
- Pamphlet Number
- 1493
- Available Online
- View Pamphlet
Erythropoiesis-stimulating agents (ESAs) are a group of medicines that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This can cause their red blood cell count to drop and anemia (not enough red blood cells or hemoglobin in the blood) to develop. How to take and store this medicine and possible side effects to watch for are reviewed.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Renal Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2020
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([4] p.) : digital, PDF file
- Subjects (MeSH)
- Renal insufficiency, chronic - complications
- Anemia - drug therapy
- Hematinics - therapeutic use
- Subjects (LCSH)
- Chronic renal failure--Complications
- Hematopoietic growth factors
- Renal anemia--Chemotherapy
- Abstract
- Erythropoiesis-stimulating agents (ESAs) are a group of medicines that help take the place of a hormone called erythropoietin (EPO). People with chronic kidney disease (CKD) may not have enough EPO coming from their kidneys to tell their body to make more red blood cells. This can cause their red blood cell count to drop and anemia (not enough red blood cells or hemoglobin in the blood) to develop. How to take and store this medicine and possible side effects to watch for are reviewed.
- Responsibility
- Prepared by: Renal Program
- Pamphlet Number
- 1493
Extravasation Care for Cancer Patients
https://libcat.nshealth.ca/en/permalink/chpams37383
Nova Scotia Health. Cancer Care Program.
[Halifax, NS]:
Nova Scotia Cancer Care Program
, 2019.
- Pamphlet Number
- 0069
- Available Online
- View Pamphlet
Instructions for chemotherapy patients who experience extravasation during treatment are outlined.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health. Cancer Care Program
- Place of Publication
- [Halifax, NS]
- Publisher
- Nova Scotia Cancer Care Program
- Date of Publication
- 2019
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document : digital, PDF file
- Subjects (MeSH)
- Extravasation of Diagnostic and Therapeutic Materials
- Home Nursing
- Neoplasms - drug therapy
- Patient Safety
- Subjects (LCSH)
- Cancer--Chemotherapy--Complications
- Home nursing
- Patient safety
- Specialty
- Medical Oncology
- Pharmacy
- Abstract
- Instructions for chemotherapy patients who experience extravasation during treatment are outlined.
- Responsibility
- prepared by Nova Scotia Health Authority Cancer Care Program
- Pamphlet Number
- 0069
From Local Invasion to Metastatic Cancer : Involvement of Distant Sites Through the Lymphovascular System
https://libcat.nshealth.ca/en/permalink/provcat28422
edited by Stanley P. L. Leong.
--Totowa, NJ:
Humana Press
, c2009.
- Available Online
- View e-Book
- Location
- Online
- Available Online
- View e-Book
- Author
- Leong, Stanley P. L
- Responsibility
- edited by Stanley P. L. Leong
- Place of Publication
- Totowa, NJ
- Publisher
- Humana Press
- Date of Publication
- c2009
- Series Title
- Current clinical oncology
- ISBN
- 9781603270878
- Subjects (MeSH)
- Antineoplastic Combined Chemotherapy Protocols
- Disease Progression
- Lymphangiogenesis - drug effects
- Lymphatic Metastasis
- Neoplasm Invasiveness
- Neovascularization, Pathologic - physiopathology
- Format
- e-Book
- Location
- Online
General Chemotherapy Information
https://libcat.nshealth.ca/en/permalink/chpams37984
IWK. Hematology / Oncology, IWK. Nephrology.
Halifax, NS:
IWK Health Centre
, 2020.
- Pamphlet Number
- PL-1105
- Available Online
- View Pamphlet
Chemotherapy is medicine that treats cancer by stopping cells from growing, or by destroying cells. Several types of chemotherapies may be used. This is because they each stop cell growth or destroy cells in a different way.
- Available Online
- View Pamphlet
- Corporate Author
- IWK. Hematology / Oncology
- IWK. Nephrology
- Alternate Title
- IWK Hematology Oncology Service
- Place of Publication
- Halifax, NS
- Publisher
- IWK Health Centre
- Date of Publication
- 2020
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document : digital, PDF file
- Subjects (MeSH)
- Antineoplastic Agents
- Neoplasms - drug therapy
- Subjects (LCSH)
- Antineoplastic agents
- Chemotherapy
- Abstract
- Chemotherapy is medicine that treats cancer by stopping cells from growing, or by destroying cells. Several types of chemotherapies may be used. This is because they each stop cell growth or destroy cells in a different way.
- Responsibility
- IWK Hematology / Oncology, Halifax, NS
- Pamphlet Number
- PL-1105
Getting chemotherapy by an elastomeric infusion pump
https://libcat.nshealth.ca/en/permalink/chpams37604
Nova Scotia Health. Cancer Care Program.
Halifax, NS:
Nova Scotia Health Cancer Care Program
, 2022.
- Pamphlet Number
- 4032
- Available Online
- View Pamphlet
An elastomeric infusion pump is a lightweight disposable pump that may be used to give you medications. It is made of very hard plastic and looks like a baby bottle. This pump lets you receive medications safely and comfortably in your own home. This pamphlet explains what types of drugs can be given by an infusion pump, how an infusion pump works, whether you will still have to come to the hospital, how to carry and take care of the pump, whether you can bathe or shower with the pump, and how …
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health. Cancer Care Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Cancer Care Program
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (4 p.) : digital, PDF file
- Subjects (MeSH)
- Neoplasms
- Chemotherapy
- Infusion Pump
- Subjects (LCSH)
- Cancer
- Chemotherapy
- Specialty
- Cancer Care
- Abstract
- An elastomeric infusion pump is a lightweight disposable pump that may be used to give you medications. It is made of very hard plastic and looks like a baby bottle. This pump lets you receive medications safely and comfortably in your own home. This pamphlet explains what types of drugs can be given by an infusion pump, how an infusion pump works, whether you will still have to come to the hospital, how to carry and take care of the pump, whether you can bathe or shower with the pump, and how you will know when it is empty. Information on what to do if you think the pump is not running, if the gripper needle comes out, if the pump leaks, or if the tubing becomes disconnected is included. Signs of infection are listed.
- Responsibility
- Prepared by: Nova Scotia Health Cancer Care Program
- Pamphlet Number
- 4032
Nova Scotia Health. Cancer Care Program.
[Halifax, NS]:
Nova Scotia Cancer Care Program
, 2018.
- Pamphlet Number
- 0005
- Available Online
- View Pamphlet
Hair loss, known as alopecia (pronounced ‘al-o-peesha’), is a common side effect of cancer treatment. This pamphlet includes information on the amount of hair, why it is being lost, if it will grow back, coping mechanisms for hair loss, and questions to ask your health care team.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health. Cancer Care Program
- Place of Publication
- [Halifax, NS]
- Publisher
- Nova Scotia Cancer Care Program
- Date of Publication
- 2018
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document (3 p.) : digital, PDF file
- Subjects (MeSH)
- Alopecia
- Antineoplastic Agents - adverse effects
- Drug-Related Side Effects and Adverse Reactions
- Specialty
- Self Care
- Therapeutics
- Abstract
- Hair loss, known as alopecia (pronounced ‘al-o-peesha’), is a common side effect of cancer treatment. This pamphlet includes information on the amount of hair, why it is being lost, if it will grow back, coping mechanisms for hair loss, and questions to ask your health care team.
- Notes
- Patient & family guide
- Responsibility
- prepared by Nova Scotia Cancer Care Program
- Pamphlet Number
- 0005
How to clean up a chemotherapy drug spill at home
https://libcat.nshealth.ca/en/permalink/chpams37602
Nova Scotia Health. Cancer Care Program.
Halifax, NS:
Nova Scotia Health Cancer Care Program
, 2022.
- Pamphlet Number
- 4033
- Available Online
- View Pamphlet
When a drug spill occurs at home, precautions must be taken to make sure that other people who may be helping you with the cleanup do not come in contact with your cancer treatment. Although the risk is very low, it is important to be careful. This pamphlet gives step by step instructions to clean up a chemotherapy drug spill at home.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health. Cancer Care Program
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Cancer Care Program
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (MeSH)
- Neoplasms
- Chemotherapy
- Subjects (LCSH)
- Cancer
- Chemotherapy
- Specialty
- Cancer Care
- Abstract
- When a drug spill occurs at home, precautions must be taken to make sure that other people who may be helping you with the cleanup do not come in contact with your cancer treatment. Although the risk is very low, it is important to be careful. This pamphlet gives step by step instructions to clean up a chemotherapy drug spill at home.
- Responsibility
- Prepared by: Nova Scotia Health Cancer Care Program
- Pamphlet Number
- 4033
Induction Chemotherapy : Systemic and Locoregional
https://libcat.nshealth.ca/en/permalink/provcat40104
Karl Reinhard Aigner, Frederick O. Stephens, editors.
(2nd ed.)
--Cham:
Springer
, c2016.
- Available Online
- View e-Book
- Location
- Online
This book presents the full range of management techniques and practices used in induction chemotherapy--both systemic and locoregional--by experienced international groups within one accessible volume. It provides the latest information on the pioneering and cutting-edge practices employed in different institutions and documents the advantages of integrated treatment schedules. All those responsible for treating patients with locally advanced cancers may find new, interesting aspects of locore…
- Available Online
- View e-Book
- Other Authors
- Aigner, Karl Reinhard
- Stephens, Frederick O
- Responsibility
- Karl Reinhard Aigner, Frederick O. Stephens, editors
- Edition
- 2nd ed.
- Place of Publication
- Cham
- Publisher
- Springer
- Date of Publication
- c2016
- Physical Description
- 1 online resource (vii, 506 p. : 131 illus., 86 illus. in color)
- ISBN
- 9783319287737
- 9783319287713 (print ed.)
- Subjects (MeSH)
- Antineoplastic Agents - administration & dosage
- Induction Chemotherapy - methods
- Infusions, Intra-Arterial - methods
- Neoplasms - drug therapy
- Remission Induction - methods
- Abstract
- This book presents the full range of management techniques and practices used in induction chemotherapy--both systemic and locoregional--by experienced international groups within one accessible volume. It provides the latest information on the pioneering and cutting-edge practices employed in different institutions and documents the advantages of integrated treatment schedules. All those responsible for treating patients with locally advanced cancers may find new, interesting aspects of locoregional cancer management and will find this book to be an invaluable source of up-to-date information. Throughout the world, induction chemotherapy is being used as part of an integrated plan of management for locally advanced, solid tumors, while systemic chemotherapy is most commonly used to shrink primarily non-operable tumors. In cases of poorly or nonresponsive tumors, attempts have been made to administer chemotherapeutics via the arterial route in order to achieve higher localized drug exposure and response rates. Such therapies are being practiced worldwide in independent, remote departments in universities, teaching hospitals and clinical schools. Frequently, however, these teams remain relatively unaware of the work being done in other institutions, which may slow further progress.
- Contents
- Introduction: Overview, History, Terminology and Early Clinical Experience -- The Principle of Dose-Response in Antineoplastic Drug Delivery -- Drug Removal Systems and Induction Chemotherapy -- Cryotherapy -- Local and Regional Hyperthermia -- The Role of Hypoxia and Hyperthermia in Chemotherapy -- Induction Chemotherapy in Head and Neck Cancers -- Isolated Thoracic Perfusion with Carotid Artery Infusion for Advanced and Chemoresistant Tumors of the Parotid Gland -- Induction Chemotherapy For Breast Cancer -- Patients with Locally Advanced Breast Cancer receiving Intra-Arterial Induction Chemotherapy: report of a Phase II Clinical Study -- Regional Chemotherapy with Thoracic Wall Recurrence and Metastasized Breast Cancer -- Cytoreductive Surgery and ÇHyperthermic Intraperitoneal Chemotherapy-HIPEC -- Induction Bidirectional Chemotherapy for Gastric Cancer with Peritoneal Dissemination -- Esophageal Cancer -- Gastric Cancer -- Systemic and Regional Chemotherapy for Advanced and Metastasized Pancreatic Cancer -- Interventional Radiological Procedures for Port-Catheter Implantation -- Induction chemotherapy for hepatocellular carcinoma -- Transarterial Treatment of Primary and Secondary Liver Tumors -- Pelvic Perfusion for Rectal Cancer -- Isolated Pelvic Perfusion with Chemofiltration for Pelvic Malignancies: Anal, Cervical and Bladder Cancer -- Penile cancer treated by intra-arterial infusion chemotherapy -- Systemic Induction Chemotherapy for Advanced Stage Epithelial Ovarian Cancer -- Regional Chemotherapy in Recurrent Platinum-Refractory Ovarian Cancer -- Isolated Limb Perfusion for Melanoma -- Isolated Limb Infusion -- Induction treatment in sarcomas -- Isolated Limb Perfusion for Locally Advanced Soft Tissue Sarcoma -- Induction Chemotherapy in Treatment of Sarcomas -- Isolation Perfusion Systems: Lungs -- Metastatic Cancers in Lung: Isolated Lung Perfusio: Clinical Studies -- Isolated Thoracic Perfusion with Chemofiltration (ITP-F) for Advanced and Pre-treated Non-Small-Cell Lung Cancer -- Toxicity Profiles with Systemic versus Regional Chemotherapy.
- Format
- e-Book
- Location
- Online
[In French] Méthotrexate
https://libcat.nshealth.ca/en/permalink/chpams37947
IWK. Rheumatology.
Halifax, NS:
IWK Health Centre
, 2021.
- Pamphlet Number
- PL-0723-FR
- Available Online
- View Pamphlet
In French. Information on dosage, monitoring and blood work.
- Available Online
- View Pamphlet
- Corporate Author
- IWK. Rheumatology
- Alternate Title
- Information à l'intention du patient
- Division de rhumatologie
- Methotrexate Patient Information
- Division of Rheumataology
- Place of Publication
- Halifax, NS
- Publisher
- IWK Health Centre
- Date of Publication
- 2021
- Format
- Pamphlet
- Language
- French
- Physical Description
- 1 electronic document : digital, PDF file
- Subjects (MeSH)
- Antirheumatic Agents
- Methotrexate
- Pharmaceutical Preparations
- Rheumatic Diseases - drug therapy
- Subjects (LCSH)
- Antirheumatic agents
- Rheumatism--Chemotherapy
- Abstract
- In French. Information on dosage, monitoring and blood work.
- Notes
- The English version of this pamphlet is also available.
- Responsibility
- IWK Rheumatology, Halifax, NS
- Pamphlet Number
- PL-0723-FR
[In French] Renseignements généraux sur la chimiothérapie
https://libcat.nshealth.ca/en/permalink/chpams38007
IWK. Hematology / Oncology, IWK. Nephrology.
Halifax, NS:
IWK Health Centre
, 2020.
- Pamphlet Number
- PL-1105-FR
- Available Online
- View Pamphlet
In French. La chimiothérapie est un traitement contre le cancer qui empêche les cellules de croître ou qui les détruit. Plusieurs types de chimiothérapie peuvent être utilisés, parce que chaque type de chimiothérapie travaille d’une façon différente pour détruire les cellules ou empêcher leur croissance. / Chemotherapy is medicine that treats cancer by stopping cells from growing, or by destroying cells. Several types of chemotherapies may be used. This is because they each stop cell growth or …
- Available Online
- View Pamphlet
- Corporate Author
- IWK. Hematology / Oncology
- IWK. Nephrology
- Alternate Title
- Service d’hématologie et d’oncologie du IWK
- General Chemotherapy Information
- IWK Hematology Oncology Service
- Place of Publication
- Halifax, NS
- Publisher
- IWK Health Centre
- Date of Publication
- 2020
- Format
- Pamphlet
- Language
- French
- Physical Description
- 1 electronic document : digital, PDF file
- Subjects (MeSH)
- Antineoplastic Agents
- Neoplasms - drug therapy
- Subjects (LCSH)
- Antineoplastic agents
- Chemotherapy
- Abstract
- In French. La chimiothérapie est un traitement contre le cancer qui empêche les cellules de croître ou qui les détruit. Plusieurs types de chimiothérapie peuvent être utilisés, parce que chaque type de chimiothérapie travaille d’une façon différente pour détruire les cellules ou empêcher leur croissance. / Chemotherapy is medicine that treats cancer by stopping cells from growing, or by destroying cells. Several types of chemotherapies may be used. This is because they each stop cell growth or destroy cells in a different way.
- Responsibility
- IWK Hematology / Oncology, Halifax, NS
- Pamphlet Number
- PL-1105-FR
